RhumbLine Advisers’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
RhumbLine Advisers's IRMD Position: Q2 2026 in Review
RhumbLine Advisers reduced its iRadimed (IRMD) stake by 6% in Q2 2026, selling an estimated $74K and leaving 12,690 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2197.
RhumbLine Advisers first reported a position in IRMD in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.32M in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- RhumbLine Advisers held 12,690 shares of iRadimed worth $1.21M as of Q2 2026.
- RhumbLine Advisers sold 813 iRadimed shares in Q2 2026, an estimated $74K.
- iRadimed made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2197 holding.
- RhumbLine Advisers first reported a position in iRadimed in Q4 2021 and has held it in 19 quarters since.
- RhumbLine Advisers's iRadimed position peaked at $1.32M in Q4 2025.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.